Sbi Securities Co., Ltd. In8 Bio, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in In8 Bio, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 7 shares of INAB stock, worth $2. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7Holding current value
$2% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INAB
# of Institutions
29Shares Held
16.4MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX8.6MShares$2.84 Million2.31% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.67MShares$552,6300.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$469,8860.0% of portfolio
-
683 Capital Management, LLC New York, NY1.35MShares$445,6000.03% of portfolio
-
Sigma Planning Corp Ann Arbor, MI1.04MShares$343,6550.01% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $8.09M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...